Alcosta Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Alcosta Capital Management's LLY Position: Q3 2026 in Review
Alcosta Capital Management reduced its Eli Lilly (LLY) stake by 3% in Q3 2026, selling an estimated $151K and leaving 4,083 shares worth $4.72M. The position accounts for 3.26% of the portfolio, ranked #13.
Alcosta Capital Management first reported a position in LLY in Q4 2022 and has held it in 12 quarters since. The position peaked at $7.22M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Alcosta Capital Management held 4,083 shares of Eli Lilly worth $4.72M as of Q3 2026.
- Alcosta Capital Management sold 128 Eli Lilly shares in Q3 2026, an estimated $151K.
- Eli Lilly made up 3.26% of Alcosta Capital Management's portfolio in Q3 2026, its #13 holding.
- Alcosta Capital Management first reported a position in Eli Lilly in Q4 2022 and has held it in 12 quarters since.
- Alcosta Capital Management's Eli Lilly position peaked at $7.22M in Q2 2024.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Alcosta Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.